These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17443009)

  • 1. Improving the institutional submission and approval process for clinical research protocols in oncology.
    Camacho LH; Marubio L; Purdom MA; Leonard D; Hong DS; Moulder S; Pilat SR; Kurzrock R
    J Clin Oncol; 2007 Apr; 25(12):1632-3. PubMed ID: 17443009
    [No Abstract]   [Full Text] [Related]  

  • 2. Health care disparity: an overlooked problem in phase I oncology trials.
    O'Brien TE
    J Clin Oncol; 2007 Jul; 25(21):3182-3. PubMed ID: 17634502
    [No Abstract]   [Full Text] [Related]  

  • 3. Palliative care and the ethics of research: Medicare, hospice, and phase I trials.
    Byock I
    J Support Oncol; 2003; 1(2):139-41. PubMed ID: 15352657
    [No Abstract]   [Full Text] [Related]  

  • 4. Barriers to clinical trials vary according to the type of trial and the institution.
    Govindarajan R; Young JW; Harless CL; Hutchins LF
    J Clin Oncol; 2007 Apr; 25(12):1633-4; author reply 1634. PubMed ID: 17443010
    [No Abstract]   [Full Text] [Related]  

  • 5. Discrete event simulation applied to pediatric phase I oncology designs.
    Barrett J; Skolnik J; Jayaraman B; Patel D; Adamson P
    Clin Pharmacol Ther; 2008 Dec; 84(6):729-33. PubMed ID: 18923388
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of independent review to insure ethical quality-improvement activities in oncology: a commentary on the national debate regarding the distinction between quality-improvement initiatives and clinical research.
    Markman M
    Cancer; 2007 Dec; 110(12):2597-600. PubMed ID: 17960605
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase III trials in oncology: setting standards of care?
    Seeber S; Braun AH
    Nat Clin Pract Oncol; 2005 Sep; 2(9):426-7. PubMed ID: 16264993
    [No Abstract]   [Full Text] [Related]  

  • 8. The ethics of phase 0 oncology trials.
    Abdoler E; Taylor H; Wendler D
    Clin Cancer Res; 2008 Jun; 14(12):3692-7. PubMed ID: 18559585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phase III candidate: can we improve the science of selection?
    Bajorin D
    J Clin Oncol; 2004 Jan; 22(2):211-3. PubMed ID: 14665614
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost effectiveness, chemotherapy, and the clinician.
    Griggs JJ; Sorbero ME
    Breast Cancer Res Treat; 2009 Apr; 114(3):597-8. PubMed ID: 18695985
    [No Abstract]   [Full Text] [Related]  

  • 11. Industry, clinical trials, and the cost of cancer drugs: an investor's perspective.
    Fiorino T
    J Clin Oncol; 2007 Jul; 25(19):e21-3. PubMed ID: 17602065
    [No Abstract]   [Full Text] [Related]  

  • 12. Informing prospective research subjects of the influence of regulatory requirements for drug approval on the design of clinical trials in oncology.
    Markman M
    Cancer; 2007 Mar; 109(6):1003-6. PubMed ID: 17311306
    [No Abstract]   [Full Text] [Related]  

  • 13. Curbing industry sponsor's incentive to design post-approval trials that are suboptimal for informing prescribers but more likely than optimal designs to yield favorable results.
    Falit BP
    Seton Hall Law Rev; 2007; 37(4):969-1049. PubMed ID: 18363220
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trials and tribulations. Spiraling costs threaten gridlock.
    Malakoff D
    Science; 2008 Oct; 322(5899):210-3. PubMed ID: 18845742
    [No Abstract]   [Full Text] [Related]  

  • 15. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long overdue: phase II studies in older cancer patients: where does the FDA stand?
    Balducci L; Tam-McDevitt J; Hauser R; Simon J
    J Clin Oncol; 2008 Mar; 26(8):1387-88. PubMed ID: 18323564
    [No Abstract]   [Full Text] [Related]  

  • 17. The importance of practice patterns.
    Scott RS
    Adm Radiol; 1995 Nov; 14(11):74, 76. PubMed ID: 10154788
    [No Abstract]   [Full Text] [Related]  

  • 18. [Quality management within the competence network of paediatric oncology and haematology].
    Creutzig U; Zimmermann M; Hannemann J; Krämer I; Herold R; Henze G
    Klin Padiatr; 2003; 215(6):338-40. PubMed ID: 14677099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase 0 clinical trials in oncology: a paradigm shift for early drug development?
    Takimoto CH
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):703-9. PubMed ID: 18615251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer clinical trials: the emergence and development of a new style of practice.
    Keating P; Cambrosio A
    Bull Hist Med; 2007; 81(1):197-223. PubMed ID: 17369668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.